Sort
39,280 grants matching “leukemia”
Project 2: Inhibition of RIPK1 Mediated Cell Death to Prevent GVHD
$479,401James L M Ferrara · Icahn School Of Medicine At Mount Sinai · P01 · FY2023 · CA
Project 2: Inhibition of RIPK1 Mediated Cell Death to Prevent GVHD
$479,401James L M Ferrara · Icahn School Of Medicine At Mount Sinai · P01 · FY2025 · CA
Targeting FLT3 for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia
$479,375Michael A Caligiuri · Beckman Research Institute/City Of Hope · R01 · FY2023 · CA
Targeting FLT3 for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia
$479,375Michael A Caligiuri · Beckman Research Institute/City Of Hope · R01 · FY2022 · CA
Membrane protein target for leukemia therapy
$479,360Xunlei Kang · University Of Missouri-Columbia · R37 · FY2022 · CA
Structural biology of 7SK RNP and its interaction with HIV-1 Tat
$479,352Juli F Feigon · University Of California Los Angeles · R01 · FY2023 · AI
Structural biology of 7SK RNP and its interaction with HIV-1 Tat
$479,352Juli F Feigon · University Of California Los Angeles · R01 · FY2024 · AI
ROLE OF UBIQUITIM-LIKE PROTEINS IN DICTYOSTELIU
$479,327Columbia University Health Sciences · R01 · FY2000 · GM
Mouse models of severe combined immunodeficiencies
$479,316Frederick W Alt · Beth Israel Deaconess Medical Center · P01 · FY2011 · AI
Murine gene knock-in models fo Omenn Syndrome and leaky SCID
$479,312Luigi Daniele Notarangelo · Beth Israel Deaconess Medical Center · P01 · FY2011 · AI
Dissecting and targeting canonical and non-canonical oncogenic functions of EZH2 in cancer
$479,306G Greg Wang · Univ Of North Carolina Chapel Hill · R01 · FY2023 · CA
Pre- and Postgraduate training in Molecular Hematology
$479,300J Evan Sadler · Washington University · T32 · FY2012 · HL
Regulation and manipulation of the telomerase RNA component in hematopoiesis
$479,272Suneet Agarwal · Boston Children'S Hospital · R01 · FY2022 · DK
GENETIC AND MOLECULAR STUDIES OF NEUROGENESIS
$479,229University Of Oregon · R01 · FY2002 · HD
Structural Studies of a T cell Specific Tyrosine Kinase
$479,209Amy H Andreotti · Iowa State University · R01 · FY2019 · AI
Targeted Elimination of Cancer Stem Cells for AML Therapy
$479,195Yang Liu · Children'S Research Institute · R01 · FY2013 · CA
Mouse models of severe combined immunodeficiencies
$479,142Frederick W Alt · Beth Israel Deaconess Medical Center · P01 · FY2010 · AI
Murine gene knock-in models fo Omenn Syndrome and leaky SCID
$479,139Luigi Daniele Notarangelo · Beth Israel Deaconess Medical Center · P01 · FY2010 · AI
Sensitive, unbiased, high-throughput, cellular GUIDE-seq-2 genome-wide activity assay for therapeutic genome editing INDs
$479,100Shengdar Tsai · St. Jude Children'S Research Hospital · U01 · FY2023 · AI
Ultra-sensitive, unbiased, high-throughput, biochemical CHANGE-seq genome-wide activity and gRNA sequencing assays for therapeutic genome editing INDs
$479,100Shengdar Tsai · St. Jude Children'S Research Hospital · U01 · FY2025 · AI
Ultra-sensitive, unbiased, high-throughput, biochemical CHANGE-seq genome-wide activity and gRNA sequencing assays for therapeutic genome editing INDs
$479,100Shengdar Tsai · St. Jude Children'S Research Hospital · U01 · FY2023 · AI
Ultra-sensitive, unbiased, high-throughput, biochemical CHANGE-seq genome-wide activity and gRNA sequencing assays for therapeutic genome editing INDs
$479,100Shengdar Tsai · St. Jude Children'S Research Hospital · U01 · FY2024 · AI
Sensitive, unbiased, high-throughput, cellular GUIDE-seq-2 genome-wide activity assay for therapeutic genome editing INDs
$479,100Shengdar Tsai · St. Jude Children'S Research Hospital · U01 · FY2025 · AI
Sensitive, unbiased, high-throughput, cellular GUIDE-seq-2 genome-wide activity assay for therapeutic genome editing INDs
$479,100Shengdar Tsai · St. Jude Children'S Research Hospital · U01 · FY2024 · AI
Early Imaging Detection of CV Injury after Cancer
$478,909William Gregory Hundley · Wake Forest University Health Sciences · R01 · FY2013 · CA